Q3 Earnings Alert! Plan early for this week’s stock reports with all key data in 1 placeSee list

Biovie Inc (BIVI)

NASDAQ
Currency in USD
Disclaimer
1.1800
+0.0100(+0.85%)
Closed
After Hours
1.1900+0.0100(+0.8475%)
BIVI Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
Day's Range
1.16001.1900
52 wk Range
1.040458.2000
Prev. Close
1.17
Open
1.19
Day's Range
1.16-1.19
52 wk Range
1.0404-58.2
Volume
81,854
Average Vol. (3m)
179,714
1-Year Change
-96.6%
Book Value / Share
Unlock
Fair Value
Unlock
Fair Value Upside
Unlock
BIVI Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
30.0000
Upside
+2,442.3729%
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in oversold territory
Show more

Biovie Inc Company Profile

BioVie Inc., a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of chronic debilitating conditions in the United States. Its products pipeline includes BIV201, which completed Phase IIa clinical trial for the treatment of ascites caused due to chronic liver cirrhosis; and NE3107, a potentially selective inhibitor of inflammatory extracellular single-regulated kinase, which is in Phase III clinical trial for the treatment of patients with mild to moderate Alzheimer’s disease, as well as Phase 2 clinical trial for the treatment of Parkinson’s disease. The company was formerly known as NanoAntibiotics, Inc. and changed its name to BioVie Inc. in July 2016. BioVie Inc. was incorporated in 2013 and is headquartered in Carson City, Nevada.

Compare BIVI to Peers and Sector

Metrics to compare
BIVI
Peers
Sector
Relationship
P/E Ratio
−0.3x−2.3x−0.6x
PEG Ratio
−0.010.000.00
Price / Book
0.6x1.1x2.6x
Price / LTM Sales
-11.7x3.2x
Upside (Analyst Target)
-201.5%43.9%
Fair Value Upside
Unlock9.0%7.8%Unlock

People Also Watch

8.530
LASE
+2.77%
39.5400
RBRK
+2.14%
0.1762
ACON
-5.46%
1.270
AILE
+4.10%

FAQ

What Is the Biovie (BIVI) Stock Price Today?

The Biovie stock price today is 1.18

What Stock Exchange Does Biovie Trade On?

Biovie is listed and trades on the NASDAQ stock exchange.

What Is the Stock Symbol for Biovie?

The stock symbol for Biovie is "BIVI."

What Is the Biovie Market Cap?

As of today, Biovie market cap is 9.36M.

What is Biovie Earnings Per Share?

The Biovie EPS is -7.30.

What Is the Next Biovie Earnings Date?

Biovie will release its next earnings report on Nov 27, 2024.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.